Your browser doesn't support javascript.
loading
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Roboz, Gail J; DiNardo, Courtney D; Stein, Eytan M; de Botton, Stéphane; Mims, Alice S; Prince, Gabrielle T; Altman, Jessica K; Arellano, Martha L; Donnellan, Will; Erba, Harry P; Mannis, Gabriel N; Pollyea, Daniel A; Stein, Anthony S; Uy, Geoffrey L; Watts, Justin M; Fathi, Amir T; Kantarjian, Hagop M; Tallman, Martin S; Choe, Sung; Dai, David; Fan, Bin; Wang, Hongfang; Zhang, Vickie; Yen, Katharine E; Kapsalis, Stephanie M; Hickman, Denice; Liu, Hua; Agresta, Samuel V; Wu, Bin; Attar, Eyal C; Stone, Richard M.
Afiliação
  • Roboz GJ; Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY.
  • DiNardo CD; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY.
  • de Botton S; Institut Gustave Roussy, Villejuif, France.
  • Mims AS; Ohio State University Wexner Medical Center, Columbus, OH.
  • Prince GT; The Johns Hopkins Hospital, Baltimore, MD.
  • Altman JK; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
  • Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Donnellan W; Sarah Cannon Research Institute, Nashville, TN.
  • Erba HP; UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL.
  • Mannis GN; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
  • Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO.
  • Stein AS; City of Hope Medical Center, Duarte, CA.
  • Uy GL; Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Watts JM; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
  • Fathi AT; Massachusetts General Hospital/Harvard Medical School, Boston, MA.
  • Kantarjian HM; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Choe S; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Dai D; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Fan B; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Wang H; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Zhang V; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Yen KE; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Kapsalis SM; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Hickman D; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Liu H; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Agresta SV; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Wu B; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Attar EC; Agios Pharmaceuticals, Inc, Cambridge, MA; and.
  • Stone RM; Dana-Farber Cancer Institute, Boston, MA.
Blood ; 135(7): 463-471, 2020 02 13.
Article em En | MEDLINE | ID: mdl-31841594

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Leucemia Mieloide Aguda / Glicina / Isocitrato Desidrogenase / Mutação Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Leucemia Mieloide Aguda / Glicina / Isocitrato Desidrogenase / Mutação Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos